Control of GVHD by regulatory T cells depends on TNF produced by T cells and TNFR2 expressed by regulatory T cells.
2016
Therapeutic CD4+Foxp3+ natural regulatory T cells (Tregs) can control experimental graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (allo-HCT) by suppressing conventional T cells (Tconvs). Treg-based therapies are currently tested in clinical trials with
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
35
References
71
Citations
NaN
KQI